Abstract:Background: We utilized our previous studies analyzing the reforms affecting the health sector developed in the 1990s by financial groups to frame the strategies implemented by the pharmaceutical industry to regain market positions and to understand the challenges that regulatory agencies are confronting. Methods: We followed an analytical approach for analyzing the process generated by the disputes between the financial groups and the pharmaceutical corporations and the challenges created to governmental regulation. We analyzed primary and secondary sources using situational and discourse analyses. We introduced the concepts of biomedicalization and biopedagogy, which allowed us to analyze how medicalization was radicalized. Results: In the 1990s, structural adjustment policies facilitated health reforms that allowed the entrance of multinational financial capital into publicly-financed and employer-based insurance. This model operated in contraposition to the interests of the medical industrial complex, which since the middle of the 1990s had developed silent reforms to regain authority in defining the health-ill-care model. These silent reforms radicalized the medicalization. Some reforms took place through deregulatory processes, such as allowing direct-to-consumer advertisements of prescription drugs in the United States. In other countries different strategies were facilitated by the lack of regulation of other media such as the internet. The pharmaceutical industry also has had a role in changing disease definitions, rebranding others, creating new ones, and pressuring for approval of treatments to be paid by public, employer, and private plans. In recent years in Brazil there has been a substantial increase in the number of judicial claims demanding that public administrations pay for new treatments. Conclusions: We found that the dispute for the hegemony of the health sector between financial and pharmaceutical companies has deeply transformed the sector. Patients converted into consumers are exposed to the biomedicalization of their lives helped by the biopedagogies, which using subtle mechanisms present discourses as if they are objective and created to empower consumers. The analysis of judicialization of health policies in Brazil could help to understand the complexity of the problem and to develop democratic mechanisms to improve the regulation of the health sector.

Judicialização da Saúde: Perspectivas de uma Conformação de Efetividade

Institutional strategies as a mechanism to rationalize the negative effects of the judicialization of access to medicine in Brazil

Enforcing the right to health in private health systems through judicialization What can we learn from the scoping review of the cross-national perspective?

The application of bioethics as legal basis in judicial sentences concerning right to health in Brazil

Litigation in access to universal health coverage for children and adolescents in Brazil

The High Cost of the Legal Route in Public Health: The Impact of the Judicialization of Medicines in the Municipal Unified Health System in Campinas

Economic evaluation of an active search system to monitor the outcomes of health-related claims

A territorialidade da Atenção Básica à Saúde do SUS: a difusão das clínicas médicas populares na Região Metropolitana de Belém, Pará, Brasil

Design de sistemas de diálogos e de disputas: uma forma de prevenção, gestão e resolução de conflitos pela administração pública para o novo mundo

Evaluation of drug litigation against the Campinas municipal health system from 2017 to 2021

Injustiça ambiental e suas vozes: uma discussão a partir da visão pluralista de Judith Shklar sobre a injustiça

The impact of judiciary decisions on public security policies in Brazil

Problematizando as relações entre homoparentalidade e saúde

The creation of the health consumer: challenges on health sector regulation after managed care era

Discourses and polarities concerning health promotion in the Brazilian health system

[State and capital accumulation in Brazilian health from the perspective of the Marxist Dependency Theory]

Paths and inter-mediations between Brazilian Health Services and Youth Detention Centers

PROTECTING POLITICAL RIGHTS OR INTERFERING IN THE POLITICAL ARENA?

The Protagonism of the Brazilian Health Regulatory System in the Evolution of Patient Safety in the Country: History, Dilemmas, and Current Challenges

Patentes, acesso e produção local de medicamentos: reflexões a partir de experiências no SUS

Litigating the right to health: what can we learn from a comparative law and health care systems approach